Anna Pieta-Dalla

Via Gattamelata 64
Padova, 35128, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine.

On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 21, 2024

Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases.

Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases.

Journal: EJNMMI physics
Published: July 10, 2024

LINC01605 Is a Novel Target of Mutant p53 in Breast and Ovarian Cancer Cell Lines.

LINC01605 Is a Novel Target of Mutant p53 in Breast and Ovarian Cancer Cell Lines.

Journal: International journal of molecular sciences
Published: August 09, 2023

Hyaluronan as an immunological adjuvant: a novel application for an ancient molecule.

Hyaluronan as an immunological adjuvant: a novel application for an ancient molecule.

Journal: Cellular & molecular immunology
Published: April 05, 2023

Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling.

Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling.

Journal: Frontiers in oncology
Published: June 08, 2022

Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells.

Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells.

Journal: Journal for immunotherapy of cancer
Published: June 02, 2021

Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells.

Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells.

Journal: Oncoimmunology
Published: September 14, 2020

Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines.

Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines.

Journal: Cellular & molecular immunology
Published: September 03, 2020

Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer.

Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer.

Journal: Cells
Published: May 14, 2020

A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks.

A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks.

Journal: Cytotherapy
Published: November 06, 2019

A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer.

A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 09, 2015
Showing 1-11 of 11

Last Updated: 09/26/2026